Meet the team
SeveriDx was founded as a spin-off from GeneSpector, assembling a dedicated team and advisory board to drive the mission forward.
The company benefits from the expertise of its founders and management team, including leaders from GeneSpector, the scientific advisory board of GeneSpector, and strategic partners such as Immunotech, Charles University, Lab-chain SPADIA LAB and others. The team’s deep knowledge in diagnostics and healthcare ensures the successful execution of our business plan.
Management Team
Katerina Solcova, PhD
CEO
Michal Pohludka, PhD
Execuvite Director
Barbara Hrdlickova, PhD
COO
Advisory Board
Prof. Martina Vasakova, MD PhD
Prof. Stanislav Kmoch, PhD
Dr. Martin Radina
Mikael Kubista, PhD
Thomas Schlange, PhD
SeveriDx Partners
Immunotech LLC
Clinical Trial Submission, Quality/Regulatory Affairs Management, Diagnostic Kits Production and Distribution to Clinical Trial Sites.
SPADIA
Central Facility for Collecting and Processing Clinical Samples, Conducting PCR Tests in Collaboration with Partner Diagnostic Laboratories throughout Europe.
Clinical Research Center LLC (CRC)
Clinical Trial Preparation and Management (from Planning to Reporting for Regulatory Purposes), Coordinate Study Design, Conduct, and Data Recording, Facilitate Collaboration with GPs.
Institute of Biostatistics and Analyses (IBA)
Biostatisticians – Clinical Trial Study Design (including determining sample size and statistical endpoints- primary/secondary outcomes), Statistical Analysis Plan, Data Management (to ensure accuracy and integrity), Statistical Analysis and Interpretation of Results about the Trial Outcomes.